PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Michael Scott to Speak at Orphan Drugs Conference May 8-10 in Boston, Massachusetts - Michael Scott, Chairman of the National Organization of Rare Disorders (NORD) will give a keynote presentation at the inaugural Orphan Drugs Research and Commercialization Conference to be held in Boston, MA on May 8-10, 2013, by GTC
Michael Scott to Speak at Orphan Drugs Conference May 8-10 in Boston, Massachusetts

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2013/01/21 - Michael Scott, Chairman of the National Organization of Rare Disorders (NORD) will give a keynote presentation at the inaugural Orphan Drugs Research and Commercialization Conference to be held in Boston, MA on May 8-10, 2013, by GTC.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In an effort to utilize scientific and technological advances to better diagnose and treat patients with rare diseases, NORD is currently completing a new major strategic planning process. Michael will discuss both NORD’s current and proposed new scientific- and policy-related initiatives at the meeting.

Michael will also highlight the relevance of rare disease research to the medical world as a whole, and emphasize why broader public awareness is needed of rare diseases and orphan drugs.

Michael became the Board Chair for the National Organization of Rare Disorders (NORD) in late 2011. For the past 40 years he has been involved in scientific, medical, and health-care-related communications through activities as an editor and publisher, a self-employed communications consultant, and the owner of an independent healthcare-specific communications group of companies. He now acts as a strategic adviser and communications strategist for a variety of for-profit and not-for-profit healthcare-related companies and organizations.

In addition to his current position with NORD, Michael is the Executive Vice President at Integrated HealthCom Strategies Group, Inc. in Philadelphia, Pennsylvania. He also serves as a board member of the International Myeloma Foundation and of another (non-rare) cancer foundation, Prostrate Cancer International, Inc. He is an associate member of the American Urological Association (AUA) and the American Society for Clinical Oncology (ASCO), and a member of the American Society for Hematology (ASH) and the Drug Information Association (DIA).

GTC’s inaugural Orphan Drugs Research and Commercialization Conference brings together leaders in industry, academia, government, and patient groups to dialogue about strategies to improve orphan drug research, pricing, access, and other key topics.

The conference is part of the Drug Discovery Summit 2013, and will run parallel with three other exciting conferences:

• 3rd Epigenetics in Drug Discovery
• 6th Imaging in Drug Discovery and Development
• 7th Drug Design and Medicinal Chemistry

For more information, please visit gtcbio.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Michael Scott to Speak at Orphan Drugs Conference May 8-10 in Boston, Massachusetts

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  NAKIVO, Inc.





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)